| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b995213817b623298e97ab923373e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76296b6813db2654becd60e1a14d13a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a44667259729dbc6189f57e3932085d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46a4518534e6ec7e321129543e513205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5919d6f693c5bd03e3b051143320f5f |
| publicationDate |
2018-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180117692-A |
| titleOfInvention |
Composition for improving symptoms of autism spectrum disease and method for improving symptom of autistic spectrum disease using same |
| abstract |
The present invention provides compositions effective to ameliorate the symptoms of autistic spectrum disorders. The composition is characterized by containing as an active ingredient at least one pyridoxamine compound selected from the group consisting of pyridoxamine and pharmaceutically acceptable salts thereof. The composition may be used in combination with at least one thiamine compound selected from the group consisting of thiamine derivatives and pharmaceutically acceptable salts thereof. |
| priorityDate |
2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |